<DOC>
	<DOCNO>NCT00969904</DOCNO>
	<brief_summary>Studies suggest N-acetylcysteine ( NAC ) potentially reduce inflammation hyperinflation patient COPD . In pilot study efficacy , safety tolerability high dose NAC 12 patient moderate COPD examine . These patient receive placebo 12 week NAC 12 week dosage 3 time 600 mg day top usual medication randomize crossover design . All subject follow 28 week . The effect high dose NAC small airway assess measure total peripheral airway resistance calculate Computational Fluid Dynamics ( CFD ) . The effect oxidative stress assess measure exhale NO specific marker ( CRP , erythrocyte sedimentation rate , IL-6 , 8-isoprostane , H2O2 , TNF-alfa , glutathione , GPX , SOD IL-8 ) blood Exhaled Breath Condensate ( EBC ) . Dynamic static lung volume assess spirometry , body plethysmography diffusion . Quality life symptom assess St George Respiratory Questionnaire .</brief_summary>
	<brief_title>Pilot Study Assess Effect High Dose N-acetylcysteine ( NAC ) Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1 . Patients document COPD base follow criterion : Smoking history least 10 packyears Decreased Tiffeneau index ( FEV1/ ( FVC &lt; 0.70 ) 2 . Patients age â‰¥ 40 year 3 . Patients stop smoke since 1 month 4 . Patients present moderate COPD FEV1 50 80 % predict ( GOLD 2 ) 5 . Patients treat accord GOLD guideline 1 . Unstable patient develop exacerbation last 8 week 2 . Patients current smoker stop less 1 month 3 . Patients allergic acetylcysteine another element product 4 . Patients phenylketonuria untreated active peptic ulcer 5 . Patients stage kidney and/or heart insufficiency hypertension 6 . Patients already treat NAC 6 month last 3 month 7 . Patients continuous treatment oral , inhalation , intravenous intramuscular corticosteroid 8 . Patients pregnant breastfeed 9 . Patients treat orally administer cephalosporins 10 . Patients use supplement contain antioxidant vitamin C E</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>